Abstract
Treatment for small-cell lung cancer (SCLC) has changed little over the past few decades; available therapies have failed to extend survival in advanced disease. In recent years, immunotherapy with treatments such as interferons, TNFs, vaccines and immune checkpoint inhibitors has advanced and shown promise in the treatment of several tumor types. Immune checkpoint inhibitors such as ipilimumab, nivolumab, pembrolizumab, durvalumab, tremelimumab and ulocuplumab are at the forefront of immunotherapy and have achieved approvals for certain cancer types, including melanoma (ipilimumab, nivolumab and pembrolizumab), non-SCLC (nivolumab and pembrolizumab) and renal cell carcinoma (nivolumab). Clinical trials are investigating different immunotherapies in patients with other solid and hematologic malignancies, including SCLC. We review emerging evidence supporting the use of immunotherapy in SCLC patients.
References
May 14, 1996·Proceedings of the National Academy of Sciences of the United States of America·R B Darnell
Feb 19, 1999·Lancet·P MaddisonR L Souhami
Sep 28, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lee M KrugPhilip O Livingston
Sep 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giuseppe GiacconeCatherine Legrand
Feb 10, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Scott J AntoniaDmitry I Gabrilovich
Apr 15, 2006·The Oncologist·Remco van HorssenAlexander M M Eggermont
May 6, 2008·Journal of Neuroimmunology·Takashi TaniMasatoyo Nishizawa
Nov 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kenichi KoyamaFumitake Gejyo
Nov 26, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jedd D WolchokF Stephen Hodi
Jan 28, 2010·British Journal of Cancer·M PuglisiM E R O'Brien
Jan 12, 2011·Annual Review of Immunology·Matthew D VeselyMark J Smyth
Mar 26, 2011·Science·Robert D SchreiberMark J Smyth
Aug 4, 2011·Cancer Immunology, Immunotherapy : CII·Lee M KrugPhilip O Livingston
Dec 24, 2011·Nature·Ira MellmanGlenn Dranoff
Mar 23, 2012·Nature Reviews. Cancer·Drew M Pardoll
Aug 1, 2012·Chest·Wei WangTariq Sethi
Aug 4, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M ReckT J Lynch
Sep 4, 2012·Nature Genetics·Martin PeiferRoman K Thomas
Sep 4, 2012·Journal of Oncology Practice·Aafia ChaudhryRobert S Miller
Apr 3, 2013·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·David R Spigel, Mark A Socinski
Aug 1, 2013·Drug Design, Development and Therapy·Konstantinos ZarogoulidisGeorgios Kyriazis
Mar 4, 2014·Therapeutic Advances in Medical Oncology·Nobuhiro AsaiAkihito Kubo
May 27, 2014·Cancer Chemotherapy and Pharmacology·Rathi N PillaiJoan H Schiller
Oct 23, 2014·Cancer·Lauren Averett Byers, Charles M Rudin
Nov 11, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Hidenobu IshiiTomoaki Hoshino
Aug 11, 2015·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Takao YoshidaYukiya Ohyama
Sep 22, 2015·The Lancet Oncology·Allison Landman
Oct 22, 2015·Drugs of Today·X Rabasseda
Apr 12, 2016·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Manabu AmanoYasushi Otsuka
Citations
Nov 11, 2016·Human Vaccines & Immunotherapeutics·Ana P S SilvaPatricia U Simioni
Jul 28, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Martin ReckDavid Spigel
Oct 28, 2017·Nature Reviews. Cancer·Adi F GazdarJohn D Minna
Jul 12, 2018·Artificial Cells, Nanomedicine, and Biotechnology·Md Habban AkhterJaved Ahmad
Jul 19, 2019·The Journal of International Medical Research·Hua LuoCaoyuan Yao
Jun 15, 2018·Oncotarget·Ravi SalgiaMartin Sattler
Apr 30, 2019·The Journal of Clinical Investigation·Patrick KellishMaria Zajac-Kaye
Aug 6, 2020·Journal of Clinical Medicine·Shanmuga SubbiahRavi Salgia
Sep 10, 2020·Cancers·Giovanna EspositoAlessandro Morabito
Jun 4, 2020·Investigational New Drugs·Zi-Wen HanHong-Wu Xin
May 1, 2017·Medical Oncology·Alfredo TartaroneMichele Aieta
Oct 3, 2020·Bioscience Reports·Anfang CuiWei Yu
Feb 17, 2021·Cancer Treatment and Research Communications·Alessandro Rizzo, Giovanni Brandi
Nov 18, 2020·International Journal of Molecular Sciences·Shreepa J ChauhanRavi P Sahu
Oct 1, 2020·Biochemical and Biophysical Research Communications·Ziyang WangShuai Chen
May 3, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Sandra Cristea, Julien Sage
Jun 12, 2021·Immunotherapy·Xingyu LiuJun Chen
Jun 23, 2021·Medical Oncology·Murat Araz, Melek Karakurt Eryilmaz
Sep 16, 2021·Immunity, Inflammation and Disease·Haitao GuFeng Sun
Oct 16, 2019·Oncology Research·Jianping XuYuankai Shi